Sheethal Jose

发表

The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results

David C. Kochan, P. Caraballo, J. Olson, 2018, Mayo Clinic proceedings.

IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent.

S. Sung, Saleh Mohammad, R. Venkatadri, 2019, Journal of autoimmunity.

Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.

Robert C. Green, Keith Marsolo, Casey Overby Taylor, 2019, American journal of human genetics.

IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.

Liping Huang, M. Okusa, D. Rosin, 2017, Journal of the American Society of Nephrology : JASN.